OMEGA THERAPEUTICS INC's ticker is and the CUSIP is 68217N105. A total of 59 filers reported holding OMEGA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $758,823 | -61.6% | 352,941 | 0.0% | 5.08% | -67.0% |
Q2 2023 | $1,976,470 | -7.1% | 352,941 | 0.0% | 15.40% | +1427.7% |
Q1 2023 | $2,128,234 | +5.6% | 352,941 | 0.0% | 1.01% | +8.7% |
Q4 2022 | $2,015,293 | +5.3% | 352,941 | 0.0% | 0.93% | -38.8% |
Q3 2022 | $1,913,000 | +42.7% | 352,941 | 0.0% | 1.52% | -26.9% |
Q2 2022 | $1,341,000 | -39.1% | 352,941 | 0.0% | 2.07% | -14.0% |
Q1 2022 | $2,202,000 | -44.9% | 352,941 | 0.0% | 2.41% | -32.1% |
Q4 2021 | $3,999,000 | -39.9% | 352,941 | 0.0% | 3.55% | -57.3% |
Q3 2021 | $6,653,000 | – | 352,941 | – | 8.31% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
72 Investment Holdings, LLC | 352,941 | $6,653,000 | 8.31% |
CHI Advisors LLC | 1,055,882 | $19,904,000 | 5.81% |
Flagship Pioneering Inc. | 25,902,269 | $488,258,000 | 5.11% |
HARBOURVEST PARTNERS LLC | 2,647,059 | $49,897,000 | 4.69% |
Octagon Capital Advisors LP | 370,279 | $6,980,000 | 1.72% |
Monashee Investment Management LLC | 441,176 | $8,316,000 | 1.54% |
Artal Group S.A. | 2,273,530 | $42,856,000 | 0.96% |
SPHERA FUNDS MANAGEMENT LTD. | 527,948 | $9,952,000 | 0.84% |
PLATINUM INVESTMENT MANAGEMENT LTD | 500,000 | $9,425,000 | 0.26% |
Logos Global Management LP | 88,235 | $1,663,000 | 0.12% |